OnabotulinumtoxinA affects cortical recovery period but not occurrence or propagation of cortical spreading depression in rats with compromised blood–brain barrier
Open Access
- 4 February 2021
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Pain
- Vol. 162 (9), 2418-2427
- https://doi.org/10.1097/j.pain.0000000000002230
Abstract
OnabotulinumtoxinA (BoNT-A) is an FDA-approved, peripherally acting preventive migraine drug capable of inhibiting meningeal nociceptors. Expanding our view of how else this neurotoxin attenuates the activation of the meningeal nociceptors, we reasoned that if the stimulus that triggers the activation of the nociceptor is lessened, the magnitude and/or duration of the nociceptors’ activation could diminish as well. In the current study, we further examine this possibility using electrocorticogram recording techniques, immunohistochemistry, and 2-photon microscopy. We report (a) that scalp (head) but not lumbar (back) injections of BoNT-A shorten the period of profound depression of spontaneous cortical activity that follows a pinprick-induced cortical spreading depression (CSD), (b) that neither scalp nor lumbar injections prevent the induction, occurrence, propagation, or spreading velocity of a single wave of CSD, (c) that cleaved SNAP25 - one of the most convincing tools to determine the anatomical targeting of BoNT-A treatment - could easily be detected in pericranial muscles at the injection sites and in nerve fibers of the intracranial dura, but not within any cortical area affected by the CSD, (d) that the absence of cleaved SNAP25 within the cortex and pia is unrelated to whether the blood brain barrier (BBB) is intact or compromised, and (e) that BoNT-A does not alter vascular responses to CSD. To the best of our knowledge, this is the first report of peripherally applied BoNT-A ability to alter a neuronal function along a CNS pathway involved in the pathophysiology of migraine.Keywords
This publication has 53 references indexed in Scilit:
- Activation of central trigeminovascular neurons by cortical spreading depressionAnnals of Neurology, 2010
- Clinical Relevance of Cortical Spreading Depression in Neurological Disorders: Migraine, Malignant Stroke, Subarachnoid and Intracranial Hemorrhage, and Traumatic Brain InjuryJournal of Cerebral Blood Flow & Metabolism, 2010
- Activation of Meningeal Nociceptors by Cortical Spreading Depression: Implications for Migraine with AuraJournal of Neuroscience, 2010
- Gabapentin Suppresses Cortical Spreading Depression SusceptibilityJournal of Cerebral Blood Flow & Metabolism, 2010
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trialCephalalgia, 2010
- Sensory innervation of the calvarial bones of the mouseJournal of Comparative Neurology, 2009
- Sensitization of meningeal nociceptors: inhibition by naproxenEuropean Journal of Neuroscience, 2008
- Sensitization of central trigeminovascular neurons: Blockade by intravenous naproxen infusionNeuroscience, 2007
- Terminating Migraine With Allodynia and Ongoing Central Sensitization Using Parenteral Administration of COX1/COX2 InhibitorsHeadache: The Journal of Head and Face Pain, 2005
- Perfusion‐weighted imaging defects during spontaneous migrainous auraAnnals of Neurology, 1998